Chatenoud L - Search Results

1

Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain.

Kuhn C, Rezende RM, da Cunha AP, Valette F, Quintana FJ, Chatenoud L, Weiner HL. Kuhn C, et al. Among authors: chatenoud l. J Autoimmun. 2017 Jan;76:115-122. doi: 10.1016/j.jaut.2016.10.001. Epub 2016 Oct 10. J Autoimmun. 2017. PMID: 27745778 Free PMC article.

2

[Remission of established disease in diabetic NOD mice induced by anti-CD3 monoclonal antibody].

Chatenoud L, Thervet E, Primo J, Bach JF. Chatenoud L, et al. C R Acad Sci III. 1992;315(6):225-8. C R Acad Sci III. 1992. PMID: 1468025 Clinical Trial. French.

3

Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients.

Goldberg D, Morel P, Chatenoud L, Boitard C, Menkes CJ, Bertoye PH, Revillard JP, Bach JF. Goldberg D, et al. Among authors: chatenoud l. J Autoimmun. 1991 Aug;4(4):617-30. doi: 10.1016/0896-8411(91)90181-b. J Autoimmun. 1991. PMID: 1777012

4

[T lymphocyte activation induced by monoclonal anti-CD3 antibodies: physiopathology of cytokine release].

Chatenoud L, Bach JF. Chatenoud L, et al. C R Seances Soc Biol Fil. 1991;185(5):268-77. C R Seances Soc Biol Fil. 1991. PMID: 1806186 Clinical Trial. French.

5

Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-gamma, interleukin 3 and interleukin 6 release after triggering of the CD3/T cell receptor activation pathway.

Ferran C, Dy M, Sheehan K, Schreiber R, Grau G, Bluestone J, Bach JF, Chatenoud L. Ferran C, et al. Among authors: chatenoud l. Eur J Immunol. 1991 Oct;21(10):2349-53. doi: 10.1002/eji.1830211009. Eur J Immunol. 1991. PMID: 1833202

6

In vivo T lymphocyte activation induced in mice following the injection of anti-CD3 monoclonal antibody.

Ferran C, Bluestone J, Bach JF, Chatenoud L. Ferran C, et al. Among authors: chatenoud l. Transplant Proc. 1990 Aug;22(4):1922-3. Transplant Proc. 1990. PMID: 2143865 No abstract available.

7

Monoclonal antibodies to CD3 as immunosuppressants.

Chatenoud L, Bach JF. Chatenoud L, et al. Semin Immunol. 1990 Nov;2(6):437-47. Semin Immunol. 1990. PMID: 2151769 Review.

8

Monoclonal antibodies.

Chatenoud L. Chatenoud L. Curr Opin Immunol. 1989 Dec;2(2):246-8. doi: 10.1016/0952-7915(89)90195-7. Curr Opin Immunol. 1989. PMID: 2533869 Review. No abstract available.

9

Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.

Chatenoud L, Thervet E, Primo J, Bach JF. Chatenoud L, et al. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):123-7. doi: 10.1073/pnas.91.1.123. Proc Natl Acad Sci U S A. 1994. PMID: 8278351 Free PMC article.

10

In vitro T cell unresponsiveness following low-dose injection of anti-CD3 MoAb.

Ben-Amor A, Leite-De-Moraes MC, Lepault F, Schneider E, Machavoine F, Arnould A, Chatenoud L, DY M. Ben-Amor A, et al. Among authors: chatenoud l. Clin Exp Immunol. 1996 Mar;103(3):491-8. doi: 10.1111/j.1365-2249.1996.tb08307.x. Clin Exp Immunol. 1996. PMID: 8608651 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

463 results

Search Page

Filters